58
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Pilot study of vaporization of perfluorohexane during high-frequency oscillatory ventilation in experimental acute lung injury

, , , , &
Pages 538-547 | Received 04 Feb 2010, Accepted 19 Apr 2010, Published online: 27 Sep 2010

REFERENCES

  • Fuhrman BP, Paczan PR, DeFrancisis M: Perfluorocarbon-associated gas exchange. Crit Care Med. 1991;19:712–722.
  • Ragaller M, Bleyl JU, Koch T, Albrecht DM: [From isoflurane to perfluorohexane? Perfluorocarbons—therapeutic strategies in acute lung failure]. Anaesthesist. 2000;49:291–301.
  • Leach CL, Fuhrman BP, Morin FC 3rd, Rath MG: Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study. Crit Care Med. 1993;21:1270–1278.
  • Papo MC, Paczan PR, Fuhrman BP, Steinhorn DM, Hernan LJ, Leach CL, Holm BA, Fisher JE, Kahn BA: Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med. 1996;24:466–474.
  • Hirschl RB, Pranikoff T, Wise C, Overbeck MC, Gauger P, Schreiner RJ, Dechert R, Bartlett RH: Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA. 1996;275:383–389.
  • Hirschl RB, Croce M, Gore D, Wiedemann H, Davis K, Zwischenberger J, Bartlett RH: Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;165:781–787.
  • Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tütüncü AS, Slutsky AS: Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;173:882–889.
  • Bleyl JU, Ragaller M, Tschö U, Regner M, Kanzow M, Hübler M, Rasche S, Albrecht M: Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology. 1999;91:461–469.
  • Ragaller M, Bleyl J, Tschö U, Winkler T, Regner M, Rasche S, Koch T, Albrecht M: Effects of inhalation of perfluorocarbon aerosol on oxygenation and pulmonary function compared to PGI2 inhalation in a sheep model of oleic acid-induced lung injury. Intensive Care Med. 2001;27:889–897.
  • Chan KPW, Stewart TE: Clinical use of high-frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome. Crit Care Med. 2005;33(3 Suppl):S170– S174.
  • Derdak S, Mehta S, Stewart TE, Smith T, Rogers M, Buchman TG, Carlin B, Lowson S, Granton J: Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial (MOAT) Study Investigators. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med. 2002;166:801–808.
  • Wunsch H, Mapstone J: High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2004(1):CD004085.
  • Dunlap RD, Murphy CJ, Bedford RG: Some physical properties of perfluoro-n-hexane. J Am Chem Soc. 1958;80:83–85.
  • Stiles VE, Cady GH: Physical properties of perfluoro-n-hexane and perfluoro-2-methylpentane. J Am Chem Soc. 1952;74:3771–3773.
  • Froese AB: The incremental application of lung-protective high-frequency oscillatory ventilation. Am J Respir Crit Care Med. 2002;166:786–787.
  • Kacmarek RM: Ventilatory management of ARDS: high frequency oscillation and lung recruitment! Crit Care. 2006;10:158.
  • Kolton M, Cattran CB, Kent G, Volgyesi G, Froese AB, Bryan AC. Oxygenation during high-frequency ventilation compared with conventional mechanical ventilation in two models of lung injury. Anesth Analg. 1982;61:323–332.
  • Karmrodt J, David M, Yuan S, Markstaller K: Alternative protocol to initiate high-frequency oscillatory ventilation: an experimental study. Crit Care. 2006;10:R138.
  • Bleyl JU, Ragaller M, Tschö U, Regner M, Hübler M, Kanzow M, Vincent O, Albrecht M: Changes in pulmonary function and oxygenation during application of perfluorocarbon vapor in healthy and oleic acid-injured animals. Crit Care Med. 2002;30:1340–1347.
  • Gerber F, Krafft MP, Vandamme TF, Goldmann M, Fontaine P: Potential use of fluorocarbons in lung surfactant therapy. Artif Cells Blood Substit Immobil Biotechnol. 2007;35:211–220.
  • Kerr CL, McCaig LA, Veldhuizen RAW, Lewis JF: High-frequency oscillation and exogenous surfactant administration in lung-injured adult sheep. Crit Care Med. 2003;31:2520–2526.
  • Burkhardt W, Koehne P, Wissel H, Graf S, Proquitté H, Wauer RR, Rüdiger M: Intratracheal perfluorocarbons diminish LPS-induced increase in systemic TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1043–L1048.
  • Gama de Abreu M, Wilmink B, Hübler M, Koch T: Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. Anesthesiology. 2005;102:597–605.
  • Koch T, Ragaller M, Haufe D, Hofer A, Grosser M, Albrecht DM, Kotzsch M, Luther T: Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology. 2001;94:101–109.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.